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Abstract The S631C mutation in human ether-a'-go-go-related
gene (HERG) channels has previously been reported to disrupt
C-type inactivation and ion-selectivity when Cys-631 is in the
oxidized state. In this study, we report the relation between
pharmacology and C-type inactivation for HERGS631C chan-
nels. We demonstrate that HERGS631C in its reduced state is
fully blocked by 1 WM astemizole, terfenadine and dofetilide,
similar to wild-type HERG channels. In contrast, oxidized
HERGS631C is insensitive for these blockers. Our results
suggest that an interaction with HERG channels in the
inactivated state might be a common mechanism to a variety of
drugs known to block HERG channels with high affinity.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
The human ether-a'-go-go-related gene (HERG) was initially
identi¢ed by Warmke and Ganetzky [1] and encodes ion chan-
nels that give rise to currents which are nearly identical to the
rapidly activating delayed recti¢er K current, IKr [2]. Unlike
channels formed only with HERG, complexes of HERG with
MiRP1 resemble native cardiac IKr channels better in their
gating, unitary conductance, regulation by K and distinctive
biphasic inhibition by the class III anti-arrhythmic E-4031 [3].
While LQT2, one of the less common forms of the inherited
long QT syndrome (LQTS), has been linked to mutations in
the HERG gene, the acquired form of LQTS can result from
therapy with drugs that block HERG channels. This interac-
tion with HERG channels is considered as the main mecha-
nism underlying the potential cardiotoxic e¡ects caused by a
variety of drugs, including second-generation H1 anti-hista-
mines such as astemizole and terfenadine [4] and class III
anti-arrhythmic agents such as dofetilide [5] and amiodarone
[6]. LQTS is associated with syncope and sudden death caused
by abnormal repolarization and the onset of a rare but life-
threatening polymorphic ventricular tachycardia known as
torsade de pointes.
Potent HERG channel blockers have previously been re-
ported to interact preferentially with channels in either the
open state (e.g. dofetilide [5]), the inactivated state (e.g. per-
hexilline [7]) or the closed state (e.g. ketoconazole [8]). It was
previously shown that haloperidol block of HERGS631A, a
channel mutant with greatly reduced C-type inactivation, was
4-fold weaker than for wild-type (WT) HERG channels [4]. A
point mutation in the S5^S6 linker region, HERGS620T, abol-
ished high-a⁄nity block by dofetilide and also interfered with
C-type inactivation [9]. Similar phenomena have been de-
scribed for E-4031 [10] and nicotine [11].
Very recently, Fan et al. [12] described mutations of S631 to
residues of di¡erent physicochemical properties and compared
the resulting changes in the channel’s inactivation process.
The most dramatic di¡erences were obtained when this posi-
tion was occupied by a charged residue (S631K and S631E).
When S631 was replaced by a cysteine, the mutant channel
behaved like WT HERG channels when thiol groups are in the
reduced state. Oxidizing thiol groups with H2O2 or modifying
them with MTSET or MTSES disrupted C-type inactivation
and K-selectivity, similar to the phenotype of S631K and
S631E.
Since the pharmacological properties of HERGS631C are
unknown, we investigated the e¡ects of dofetilide (interacting
preferentially with channels in the open state), astemizole and
terfenadine (interacting preferentially with channels in the in-
activated state) on HERGS631C, expressed in Xenopus oo-
cytes. Currents were evoked using the two-microelectrode
voltage clamp technique.
2. Materials and methods
2.1. Expression in oocytes
The HERGS631C mutant in its original vector, pALTER (Prome-
ga, USA), was ¢rst subcloned into pGEMHE. The HERGS631C
clone was isolated by a double restriction digest with EcoRI and
XbaI and ligated into the corresponding sites of pGEMHE. The liga-
tion product, HERGS631C/pGEMHE, was linearized with XbaI and
capped cRNAs were synthesized using the large-scale T7 mMES-
SAGE mMACHINE transcription kit (Ambion, USA). The in vitro
synthesis of cRNA encoding WT HERG and isolation of Xenopus
oocytes was as previously described [13]. Oocytes were injected with
HERG or HERGS631C cRNA at a concentration of 10 ng/50 nl.
2.2. Electrophysiological recordings and analysis
Whole-cell currents from oocytes were recorded from 1 to 4 days
after injection using the two-microelectrode voltage clamp technique
(GeneClamp 500, Axon Instruments, USA). Resistances of voltage
and current electrodes were kept as low as possible (approximately
200 k6) and were ¢lled with 3 mol/l KCl. Currents were ¢ltered at
200 Hz, using a four-pole low-pass Bessel ¢lter. Capacitative and leak
currents were not subtracted. To eliminate the e¡ect of the voltage
drop across the bath grounding electrode, the bath potential was
actively controlled. All experiments were performed at room temper-
ature (19^23‡C). The oocytes were superfused with ND-96 solution
(composition in mmol/l: KCl 2, NaCl 96, MgCl2 1, CaCl2 1.8,
HEPES 5, pH 7.5). For incubation of oocytes, this solution was sup-
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plemented with 50 mg/l gentamicin sulfate. The pCLAMP program
was used for data acquisition and data ¢les (Axon Instruments, USA)
were directly imported, analyzed and visualized with a custom made
add-in for Microsoft Excel.
Current percentages were used for the calculation of concentration^
response curves, using the Hill equation:
I  Imax=1 IC50=AnH 
where I represents the current percentage, Imax the maximal current
percentage, IC50 the concentration of the agonist that evokes the half-
maximal response, A the concentration of agonist, and nH the Hill
coe⁄cient. Averaged data are indicated as mean þ S.E.M. Statistical
analysis of di¡erences between groups was carried out with Student’s t
test and a probability of 0.05 was taken as the level of statistical
signi¢cance.
2.3. Compounds
Astemizole, terfenadine and dofetilide were kind gifts from the
Janssen Research Foundation (Belgium). Compounds were dissolved
in DMSO, stored at 5‡C and diluted in ND-96 appropriately for the
experiments.
3. Results
To compare the pharmacology of WT HERG channels with
HERGS631C channels in the reduced state, we ¢rst investi-
gated the e¡ect of astemizole on WT HERG channels. HERG
cRNA was injected in Xenopus oocytes and currents were
investigated 2 days after injection using the two-microelec-
trode voltage clamp technique. HERG currents were evoked
by application of 1 s test pulses ranging from 370 to +30 mV
in 10 mV increments from a holding potential of 390 mV.
Tail currents were measured at a potential of 370 mV during
1 s (Fig. 1A). Increasing concentrations of astemizole were
applied to oocytes repeatedly pulsed to 0 mV with intervals
of 1 s from a holding potential of 390 mV (Fig. 1B). Peak tail
current amplitudes evoked at 370 mV were then used to
construct a concentration^response curve (Fig. 1C). We cal-
culated that HERG channels are blocked by astemizole with
an IC50 value of 0.735 þ 0.223 nM and a Hill coe⁄cient of
0.461 þ 0.041 (n = 4). The inhibitory e¡ect of the highest con-
centration of astemizole (1 WM) was only partially reversible
upon long washout periods (s 15 min) with ND-96 (data not
shown).
To investigate whether astemizole blocks HERGS631C
channels, HERGS631C cRNA was expressed in oocytes and
currents were investigated 2 days after injection. Currents
were evoked using the same protocols as for WT HERG chan-
nels but with longer pulse intervals (8 s) since it has been
reported that repeated pulses with high frequency to depolar-
ized potentials result in disruption of C-type inactivation and
ion-selectivity of HERGS631C [12]. When thiol groups of
Cys-631 are in the reduced state, HERGS631C currents are
characterized by fast inactivation during the test pulse and
typical inward recti¢cation of the tail currents [12], resulting
in a phenotype similar to WT HERG channels (Fig. 2A).
Under these conditions, we found that HERGS631C currents,
evoked by application of pulses to 0 mV with intervals of 8 s
from a holding potential of 390 mV, could be completely
blocked by 1 WM astemizole, as measured on the peak tail
current amplitudes (Fig. 2B).
Fig. 1. A: HERG currents were evoked under control conditions by application of 1 s test pulses ranging from 370 to +30 mV in 10 mV in-
crements from a holding potential of 390 mV. Tail currents were measured at a potential of 370 mV during 1 s. B: Increasing concentrations
of astemizole were applied to oocytes repeatedly pulsed to 0 mV with intervals of 1 s from a holding potential of 390 mV. C: Peak tail current
amplitudes evoked at 370 mV were used to construct a concentration^response curve. HERG currents are blocked by astemizole with an IC50
value of 0.735 þ 0.223 nM and a Hill coe⁄cient of 0.461 þ 0.041 (n = 4).
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Next, we investigated whether high concentrations of
other potent HERG channel blockers would a¡ect
HERGS631C channels in a similar manner. Under identical
recording conditions (i.e. thiol groups of Cys-631 in the re-
duced state), it was found that 1 WM of terfenadine (Fig. 2C)
and dofetilide (Fig. 2D) also completely block HERGS631C
channels, as measured on peak tail current amplitudes (n = 4
each). Again, the inhibitory e¡ect of the highest concentra-
tion of these drugs (1 WM) was only partially reversible upon
long washout periods (s 15 min) with ND-96 (data not
shown).
The pharmacology of HERGS631C channels with thiol
groups of Cys-631 in the oxidized state was investigated by
treating oocytes with 1% H2O2 for approximately 1 min. As
previously demonstrated under these conditions, the
HERGS631C phenotype is characterized by disrupted C-type
inactivation and K-selectivity. Representative current traces
shown in Fig. 3A were evoked by application of 1 s test pulses
ranging from 370 to +20 mV in 10 mV increments from a
holding potential of 390 mV. As a result of the disrupted ion-
selectivity, current traces inwardly activated during the test
pulse at potentials between 350 and 310 mV and outwardly
activated at test potentials more positive than 0 mV. Tail
currents inwardly deactivated at 370 mV (clearly more pos-
itive than the WT HERG Erev of approximately 390 mV).
Surprisingly, under oxidizing conditions, we found that
HERGS631C currents, evoked by application of pulses to
+20 mV with intervals of 8 s from a holding potential of
390 mV, could not be blocked by 1 WM astemizole, as meas-
ured during the test pulse (Fig. 3B). Similarly, HERGS631C
channels with thiol groups in the oxidized state were insensi-
tive to 1 WM terfenadine (Fig. 3C, n = 4) and 1 WM dofetilide
(Fig. 3D, n = 4). Current percentages calculated under these
conditions were 96.65 þ 4.77%, 95.92 þ 4.24% and 91.65 þ
3.50% for astemizole, terfenadine and dofetilide, respectively.
To investigate whether a higher pulse frequency would a¡ect
channel block, test pulses were applied with intervals of 1 s.
Under these conditions, current percentages were 90.80 þ
2.84%, 91.92 þ 2.72 and 88.72 þ 2.92 for astemizole, terfena-
dine and dofetilide, respectively (n = 4 each). Statistical anal-
ysis did not reveal a signi¢cant di¡erence.
In addition, we observed that on the same oocyte, the phar-
macology of HERGS631C channels could be driven from sen-
sitive to insensitive as a function of its redox state. As illus-
trated in Fig. 4A (peak tail current amplitudes are plotted as a
function of time), HERGS613C with thiol groups in the re-
duced state could be completely blocked by 1 WM dofetilide.
This inhibitory e¡ect was partially reversible upon continuous
perfusion with ND-96. HERGS631C currents were then inves-
tigated under oxidizing conditions (1% H2O2) and no inhib-
itory e¡ect could be observed upon a second application of
1 WM dofetilide. Data of current percentages of HERGS631C
channels with thiol groups in the reduced (K mode, ¢lled
bars) and oxidized state (Na mode, non-¢lled bars) are sum-
marized in Fig. 4B for 1 WM astemizole (n = 4), terfenadine
(n = 4) and dofetilide (n = 4).
Fig. 2. A: When thiol groups of Cys-631 are in the reduced state, HERGS631C currents are similar to WT HERG currents. HERGS631C cur-
rents were evoked using the same protocols as for WT HERG currents but with pulse intervals of 8 s. When thiol groups of Cys-631 are in the
reduced state, we found that HERGS631C currents could be completely blocked by 1 WM astemizole (B), as measured on the peak tail current
amplitudes. Other potent HERG channel blockers a¡ect HERGS631C channels in a similar manner. It was found that 1 WM of terfenadine (C)
and dofetilide (D) also completely block HERGS631C channels (n = 4 each). Currents in B, C and D were evoked by application of pulses to
0 mV with intervals of 8 s from a holding potential of 390 mV.
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4. Discussion
A preferential interaction with HERG channels in the open
state or the inactivated state has previously been shown to
underly high-a⁄nity block of HERG channels. For dofetilide
block, known to require channel opening for block to occur
and to be modulated by inactivation gating, a point mutation
in the S5^S6 linker region, HERGS620T, abolished high-a⁄n-
ity block and also interfered with C-type inactivation [9]. For
haloperidol, a drug interacting preferentially with the channel
in the inactivated state, a mutation in the pore region known
to disrupt C-type inactivation, HERGS631A, reduced the
high-a⁄nity block 4-fold [4]. Very recently, Fan et al. [12]
reported that most dramatic di¡erences were obtained when
S631 was replaced by a charged residue (S631K and S631E).
Indeed, current^voltage relationships show that the degree of
C-type inactivation is most prominent for WT HERG chan-
nels, retained (but to a lesser degree) for HERGS631A and
absent for HERGS631K and S631E [12]. Coinciding with a
dramatic loss of C-type inactivation, S631K and S631E are
characterized by disrupted K-selectivity. Interestingly, the
S631C mutant channel behaved like WT HERG channels
when thiol groups of Cys-631 are in the reduced state. Oxi-
dizing thiol groups with H2O2 or modifying them with
MTSET or MTSES disrupted C-type inactivation and K-
selectivity, similar to the phenotype of S631K and S631E [12].
In this study, we report the pharmacological properties of
the HERGS631C mutant. For this mutant in particular, the
dramatic loss of C-type inactivation can be actively controlled
as a function of the redox state of Cys-631. HERGS631C
gives rise to currents similar to WT HERG currents when
Cys-631 is in the reduced state, whereas a phenotype similar
to S631K and S631E is obtained when oocytes are treated
with H2O2. This mutant allowed us to study the relation be-
tween pharmacology and C-type inactivation of the HERG
channel by switching channels between two di¡erent states,
one characterized by fast C-type inactivation and inward rec-
ti¢cation of the tail currents, the other by delayed outward
recti¢cation and loss of K-selectivity. Voltage clamp experi-
ments were performed on Xenopus oocytes injected with
cRNA encoding WT HERG or HERGS631C.
Results from our study show that HERGS631C in its re-
duced state is fully blocked by 1 WM astemizole, similar to
WT HERG channels. Saturating concentrations from terfena-
dine, also known to bind preferentially to HERG channels in
the inactivated state, completely blocked HERGS631C chan-
nels. Similar results were obtained with 1 WM dofetilide, a
drug requiring channel opening for block to occur.
In contrast, oxidized HERGS631C (treated with H2O2) is
insensitive for 1 WM astemizole and terfenadine. This result
suggests that indeed astemizole and terfenadine interact pref-
erentially with the inactivated state, since HERGS631C be-
comes insensitive to saturating concentrations of these drugs
when C-type inactivation of the channel is dramatically dis-
Fig. 3. When thiol groups of Cys-631 are in the oxidized state, the phenotype is characterized by disrupted C-type inactivation and K-selectiv-
ity. Current traces shown in A were evoked by application of 1 s test pulses ranging from 370 to +20 mV in 10 mV increments from a holding
potential of 390 mV. Tail currents inwardly deactivated at 370 mV. When thiol groups of Cys-631 are in the oxidized state, we found that
HERGS631C currents remain una¡ected by application of 1 WM astemizole (B), as measured on the peak tail current amplitudes. It was found
that 1 WM of terfenadine (C) and dofetilide (D) had no e¡ect on HERGS631C channels either (n = 4 each). Currents were evoked by applica-
tion of pulses to 20 mV with intervals of 8 s from a holding potential of 390 mV.
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rupted. Rather surprisingly, similar results were obtained with
1 WM dofetilide. Our results show that HERGS631C in its
oxidized state becomes insensitive to 1 WM dofetilide, despite
the fact that this drug has previously been shown to interact
with the channel in its open state [5]. E¡ects which are indi-
cative for open channel block, such as apparent inactivation
during the test pulse, reduction of the peak tail current am-
plitude and slowing of channel deactivation, resulting in a
cross-over phenomenon of the tail currents [5,14], were not
observed with 1 WM dofetilide on HERGS631C in its oxidized
state. This result illustrates the importance of the inactivated
state in high-a⁄nity block of HERG by astemizole and terfe-
nadine as well as dofetilide, a drug requiring channel opening
for block to occur. However, the possibility that treatment of
HERGS631C with H2O2 disrupts the pharmacological binding
site cannot be excluded. Additionally, we show that on the
same oocyte, the pharmacology of HERGS631C can be driven
from sensitive to insensitive as a function of its redox state.
HERGS613C with thiol groups in the reduced state could be
completely blocked by 1 WM dofetilide. This inhibitory e¡ect
was partially reversible upon perfusion with ND-96. When
HERGS631C channels were then switched to its disrupted
inactivation mode (1% H2O2), no inhibitory e¡ect could be
observed upon a second application of 1 WM dofetilide.
In conclusion, our results illustrate the importance of
C-type inactivation in the pharmacological action of high-af-
¢nity channel blockers. Taken into account that a reduced
a⁄nity of haloperidol [4], azimilide, quinidine, RP58866 and
nicotine [15] has previously been reported for HERGS631A,
we suggest that an interaction with HERG channels in the
inactivated state might be a common mechanism to a variety
of drugs known to block HERG channels with high a⁄nity.
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Fig. 4. A: The pharmacology of HERGS631C channels could be
driven from sensitive to insensitive as a function of its redox state.
Peak tail current amplitudes are plotted as a function of time.
HERGS613C with thiol groups in the reduced state could be com-
pletely blocked by 1 WM dofetilide. This e¡ect was partially reversi-
ble upon continuous perfusion with ND-96. HERGS631C currents
were then investigated under oxidizing conditions (1% H2O2) and
no inhibitory e¡ect could be observed upon a second application of
1 WM dofetilide. B: Summary of current percentages of
HERGS631C channels with thiol groups in the reduced (K mode)
and oxidized (Na mode) state for 1 WM astemizole (n = 4), terfena-
dine (n = 4) and dofetilide (n = 4).
FEBS 23714 18-5-00
C. Ulens, J. Tytgat/FEBS Letters 474 (2000) 111^115 115
